Ever stared at 3 AM ceiling shadows wondering if you’re broken? I have.
Last year, my brain became a Netflix autoplay I couldn’t pause. Four hours. Every. Single. Night. Drove myself to a sleep doc convinced I needed pills—turns out, I needed *proof* first.
The brutal protocol: log your misery in a sleep diary (thanks, Dr. Harvey’s Oxford research) for 10–14 days, score your suffering on the ISI, eliminate the fakes—apnea via STOP-BANG, restless legs, that rogue thyroid. Then actigraphy or PSG if they’re stumped.
We at Corala Blanket live this grind daily—no cap, promoting actual rest is our whole thing.
And 2026? Sleepmaxxing is everywhere. Whoop bands, Eight Sleep pods, people *optimizing* what I couldn’t even access.
Here’s what nobody tells you: diagnosis requires three months of documented hell. Three months.
So tell me—are you tracking your doom, or just surviving it?
DSM-5 vs ICSD-3 Diagnostic Criteria
To get an insomnia diagnosis, I start by comparing your sleep complaint against two widely used diagnostic frameworks—DSM-5 (which frames insomnia as a persistent dissatisfaction with sleep quantity/quality) and ICSD-3/AASM (which uses a symptom-based approach). In my work, your “control levers” are clear: I focus on symptom identification—difficulty initiating sleep (falling asleep takes >20–30 minutes), difficulty maintaining sleep (frequent awakenings), early-morning awakening with inability to return to sleep, or bedtime resistance.
Then I check the pattern: DSM-5 requires symptoms at least three nights per week for three months, with enough time in bed to reasonably sleep (think “adequate sleep opportunity,” often ~7+ hours). Chronic insomnia is defined as symptoms occurring at least three times per week for three months; short-term insomnia occurs less frequently. ICSD-3/AASM is also symptom-based, counting at least one of those core nighttime problems and looking for meaningful daytime impairment.
Next, I confirm impact and rule-outs, because a diagnosis must be precise, not convenient. Your daytime effects matter: fatigue, attention or memory problems, mood disturbance, reduced motivation, and even headache or GI symptoms. At the same time, I make sure this isn’t better explained by another sleep-wake disorder, a breathing problem, a substance effect, or a coexisting mental disorder.
Chronic insomnia benchmarks are straightforward: symptoms persist ≥3 months, occur ≥3 nights/week, and cause distress or impaired functioning even when life isn’t dominated by obvious shift-work changes or transient events.
To reach a defensible conclusion, I run a structured initial consultation. I review your medical history and do a physical exam—often checking thyroid-related clues and general cardiopulmonary health. When warranted, I order blood tests to screen for issues like thyroid dysfunction.
I also collect a detailed sleep habits profile: bed and wake times, sleep onset duration, number and timing of awakenings, naps, device use before bed, exercise timing, and caffeine, alcohol, nicotine, or drug intake. Then I use tools such as the Insomnia Severity Index (ISI, 0–28) and the Athens Insomnia Scale (AIS) to quantify severity and guide clinical interview; I may also screen for sleep apnea using the STOP questionnaire.
You’ll usually keep a one-to-two week sleep diary so patterns become visible instead of debated. If the picture is uncomplicated, I don’t jump to routine PSG or MSLT. Actigraphy can add objectivity.
If comorbidities are suspected, I tailor testing and then discuss treatment options grounded in the clarified diagnosis—so you’re steering, not guessing.
First Sleep Study Results

Once the initial interview, sleep diary, and history suggest that something beyond “just insomnia” might be driving your symptoms, a first-night sleep study (usually a polysomnogram, or PSG) helps clinicians map what your body does while you’re asleep. I want you to control the process: results don’t “test for insomnia,” they rule out look-alikes. Expect brain waves, oxygen, breathing, and leg movements. In one study of chronic insomnia patients, mean sleep efficiency landed around 73.9%, with 63.2% showing poor sleep efficiency—yet some had no primary disorder. Here’s what the PSG can reveal:
| PSG signal | What it suggests |
|---|---|
| Sleep efficiency | How well you stay asleep |
| Onset latency | Time to fall asleep |
| Awakenings frequency | Sleep-maintenance problems |
| Oxygen drops | Possible sleep apnea |
| Leg movements | Possible RLS/PLMD |
FAQ
Can Insomnia Be Diagnosed Without Meeting the Exact DSM-5 Sleep Duration?
Yes, sometimes, but it’s conditional: DSM-5 sets “≥3 nights/week for ≥3 months,” yet clinicians can diagnose “insomnia disorder” without the full duration when symptoms are severe and impairing, or when other criteria strongly fit.
Interesting statistic: about 10–15% of adults report insomnia symptoms.
I use self-report tools like PSQI or ISI, and I align insomnia criteria with a 1–2 week sleep diary.
If you want control, ask your clinician about ICSD-3/AASM categories.
What Symptoms Qualify as “Clinically Significant” Daytime Impairment for Diagnosis?
Clinically significant daytime impairment means your daytime functioning visibly slips, not just that you feel “a bit off.”
I look for daytime fatigue, cognitive impairment like slowed reaction time, attention and memory lapses, and error-proneness. You might also see mood disturbance, reduced motivation, irritability, sleepiness or unrefreshing sleep causing social or occupational dysfunction—missed deadlines, mistakes at work, or withdrawing from normal activities.
Clinicians like AASM experts tie impairment to real-world impact, not inconvenience.
When Should I Request a Sleep Diary Instead of Medical Sleep Testing?
I’d request a sleep diary first when your main job is to confirm your sleep patterns, not to hunt rare physiology.
Once I met “can’t sleep” with no data; a 2-week diary (time to bed, latency, awakenings, final wake) clarified triggers and cadence.
If you’re not having excessive daytime sleepiness, snoring, leg-movement spells, or suspected narcolepsy, tracking habits beats Polysomnography.
You might escalate to PSG/MSLT if history suggests breathing or neurologic causes.
Do Prescription Medications or Withdrawal Automatically Rule Out Insomnia Diagnosis?
No. Prescription medications don’t automatically “rule out” insomnia.
Clinicians still diagnose insomnia if your sleep complaint meets DSM-5 or ICSD-3/AASM patterns (≥3 nights/week for ≥3 months, with daytime impairment) and you have adequate sleep opportunity.
The key is attribution: medication impact and withdrawal effects mustn’t better explain your symptoms.
I tell you: document which drug, dose timing, and taper/cessation dates—experts like Steensma and AASM emphasize ruling out competing causes.
What’s the Difference Between Episodic, Persistent, and Recurrent Insomnia Diagnosis?
Episodic, persistent, and recurrent insomnia classifications describe time patterns, not your character. I map them this way: episodic lasts ≥1 month but <3 months—like a flare-up.
Persistent/chronic endures ≥3 months, at least 3 nights weekly—more like a chronic clock-disruption.
Recurrent means you have ≥2 episodes within 1 year, separated by partial recovery.
These labels help clinicians gauge symptom severity, plan treatment intensity, and track relapse risk with tools like AASM and Spielman models.
References
- https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t36/
- https://www.medcentral.com/behavioral-mental/sleep-disorders/psychiatric-disorders-insomnia
- https://www.mayoclinic.org/diseases-conditions/insomnia/diagnosis-treatment/drc-20355173
- https://www.hcp.med.harvard.edu/wmh/ftpdir/affiliatedstudies_BIQ_algorithm.pdf
- https://aasm.org/wp-content/uploads/2022/05/ICSD-3-TR-Insomnia-Draft.pdf
- https://psychcentral.com/disorders/insomnia-symptoms
- https://www.sleepfoundation.org/insomnia/diagnosis
- https://www.healthquality.va.gov/guidelines/CD/insomnia/CST-03-Insomnia-Disorder-Screening-Guide-Final-508.pdf
- https://stanfordhealthcare.org/medical-conditions/sleep/insomnia/diagnosis.html
- https://aasm.org/resources/clinicalguidelines/040515.pdf



